New 2026 Prostate Cancer Screening Guidelines: When Men Should Start PSA Testing
The American Cancer Society (ACS) has officially updated its prostate cancer screening guidelines for the first time since 2010, moving away from "optional" discussions to recommending regular testing for middle-aged men.
Under the new 2026 guidelines, men at average risk between ages 50 and 69 should get a routine prostate-specific antigen (PSA) blood test every two years. Higher-risk groups—specifically Black men (who face nearly double the mortality rate) and men with a strong family history of the disease—are advised to start regular screening earlier at age 45. Screening can continue through age 75 based on individual health decisions.
Historically, routine PSA testing was debated because treating slow-growing tumors with surgery or radiation carries heavy risks like incontinence and erectile dysfunction. However, the ACS notes that modern diagnostic tools have drastically improved. Today, an elevated PSA score doesn't automatically mean an invasive biopsy or aggressive treatment; doctors now use follow-up tests, MRIs, and "active surveillance" to safely monitor harmless tumors while catching lethal ones early.
With prostate cancer standing as the second leading cause of cancer death in U.S. men, experts emphasize that a simple blood test is now a smarter, safer early-warning system.

Thompson, D. (2026, November 12). New guidelines recommend regular prostate cancer screening for all middle-aged men. Drugs.com. https://www.drugs.com/news/new-guidelines-recommend-regular-prostate-cancer-screening-all-middle-aged-men-131948.html



Comments